|
Staging is the process of finding out how far a cancer
hasspread. The stage of salivary gland cancer is one of the most
important
factors in selecting treatment options and estimating a patient's
outlook for recovery and outlook (prognosis).
The stage of a cancer is determined from the results of
physical exams, imaging tests (ultrasound, CT or MRI scan, etc.) and
other tests, which are described in the section "How
is salivary gland cancer diagnosed?", and by the results of
surgery if it has been done.
The American Joint Committee on Cancer
(AJCC) TNM system
A staging system is a standardized way for the cancer care
team to summarize information about how far a cancer has spread. The
most common system used to describe the stages of salivary gland
cancers is the TNM system of the American Joint Committee on Cancer
(AJCC). This system contains 3 key pieces of information:
- T
describes the size of the primary tumor
and whether it has invaded into nearby organs or tissues.
- N
describes whether the cancer has spread to nearby (regional) lymph nodes (bean-sized
collections of immune system cells located throughout the body).
- M indicates
whether the cancer has metastasized
(spread) to other organs of the body. (The most common site of distant
salivary gland cancer spread is the lungs.)
Numbers or letters appear after T, N, and M to provide more
details about each of these factors:
- The numbers 0 through 4 indicate increasing severity.
- The letter X means "cannot be assessed" because the
information is not available.
T groups for major salivary gland cancers
TX: The
main (primary) tumor cannot be assessed; information
not known.
T0: No
evidence of a primary tumor.
T1: Tumor
is 2 cm (about ¾ inch) across or smaller.
It is not growing into nearby tissues.
T2: Tumor
is larger than 2 cm but no larger than 4 cm (about
1½ inch) across. It is not growing into nearby tissues.
T3: Tumor is
larger than 4 cm across and/or is growing into
nearby soft tissues.
T4a: Tumor
is any size and is growing into nearby structures such as
the jaw bone, skin, ear canal, and/or facial nerve.
This is known as moderately
advanced disease.
T4b: Tumor
is any size and is growing into nearby structures such as
the base of the skull or other bones nearby, or it surrounds the
carotid artery. This is known as very
advanced disease.
N groups for major salivary gland cancers
NX: Nearby
(regional) lymph nodes cannot be assessed;
information not known.
N0: No
spread to regional lymph nodes.
N1: The
cancer has spread to 1 lymph node on the same side of
the head or neck as the primary tumor. The lymph node is smaller than 3
cm
(about 1¼ inch) across.
N2: This
group includes 3 subgroups:
- N2a: The
cancer has spread to 1 lymph node on the
same side as the primary tumor. The lymph node is larger than
3 cm but not
larger than 6 cm (about 2½ inches) across.
- N2b: The
cancer has spread to more than 1 lymph
node on the same side as the primary tumor, none of the lymph nodes are
larger
than 6 cm across.
- N2c: The
cancer has spread to 1 or more lymph
nodes, none larger than 6 cm across, either on the side opposite the
primary tumor or on both sides of the neck.
N3: The
cancer has spread to a lymph node that is larger than
6 cm across.
M groups for major salivary gland cancers
MX: Presence
of distant spread (metastasis) cannot be
assessed; information not known.
M0: The
cancer has not spread to tissues or organs far away
from the salivary glands.
M1: The
cancer has spread to tissues or organs far away from
the salivary glands.
Stage grouping
Once the T, N, and M categories have been assigned, this
information is combined in a process called stage grouping to assign an
overall stage. The stage is expressed in Roman numerals from I (the
least advanced) to IV (the most advanced). Some stages are subdivided
with letters.
Stage
I: T1, N0, M0: The
tumor is no more than 2 cm (about ¾
inch) across and is not growing into nearby tissues (T1). It has not
spread
to nearby lymph nodes (N0) or distant sites (M0).
Stage
II: T2, N0, M0: The
tumor is larger than 2 cm but is no larger
than 4 cm across and is not growing into nearby tissues (T2). It has
not
spread to nearby lymph nodes (N0) or distant sites (M0).
Stage
III: Either of the following:
T3, N0, M0: The
tumor is larger than 4 cm across and/or is
growing into nearby soft tissues (T3). It has not spread to nearby
lymph
nodes (N0) or to distant sites (M0).
OR
T1 to T3, N1, M0:
The tumor is any size and may have grown into
nearby soft tissues (T1 to T3). The cancer has spread to one lymph node
on the
same side of the head or neck as the primary tumor, but the lymph node
is no larger than 3 cm across (N1). The cancer has not spread to
distant
sites (M0).
Stage
IVA: Either of the following:
T4a, N0 or N1,
M0: The
tumor is any size but invades nearby
structures such as the jaw bone, skin, ear canal, and/or facial nerve
(T4a).
It may or may not have spread to one lymph node (no larger than 3 cm
across) on the same side of the head or neck as the primary tumor (N0
or N1). The
cancer has not spread to distant sites (M0).
OR
T1 to T4a, N2,
M0: The
tumor is any size and may or may not
invade nearby soft tissues or structures such as the jaw bone, skin,
ear canal, and/or facial nerve (T1 to T4a). The cancer has spread to
more than one
lymph node, to a lymph node larger than 3 cm across, or to lymph nodes
on the other or both sides of the neck. None of the lymph nodes are
larger than 6 cm across (N2). The cancer has not spread to distant
sites (M0).
Stage
IVB: Either of the following:
T4b, Any N, M0: The
tumor is any size and invades nearby
structures such as the base of the skull or other bones nearby, or it
surrounds the carotid artery (T4b). The cancer may or may not have
spread to
nearby lymph nodes (any N). It has not spread to distant sites (M0).
OR
Any T, N3, M0: The
tumor is any size and may or may not have
invaded nearby soft tissues or other structures (any T). The cancer has
spread
to at least 1 lymph node that is larger than 6 cm across (N3). It has
not
spread to distant sites (M0).
Stage IVC: Any
T, Any N, M1:
The tumor is any size and may or may not
have invaded nearby soft tissues or other structures (any T). The
cancer may or
may not have spread to nearby lymph nodes (any N). It has spread to
distant
sites (M1).
If you have any questions about the stage of your cancer or
how it affects your treatment, be sure to ask your cancer care team.
Survival rates for salivary gland cancer by
stage
Survival rates are a way for doctors to discuss and compare
the prognosis (outlook) for patients, based on the stage of the cancer
or other traits. The numbers below are relative survival rates
calculated from the National Cancer Institute's Surveillance,
Epidemiology, and End Results (SEER) database, based on people who were
diagnosed with salivary gland cancer between 1988 and 2001. There are
some important points to note about these numbers:
- The survival
rate refers to the percentage of
patients who live at
least a certain number of years after being
diagnosed. Many patients live much longer than this.
- Relative
survival rates (such as the numbers below)
compare the observed survival rate with that expected for people
without salivary gland cancer. This means that relative survival rates
only refer to deaths from the cancer in question. They are considered
to be a more accurate way to describe the outlook for patients with a
particular type and stage of cancer.
- These numbers were derived from patients treated at
least several years ago. These are some of the most current numbers we
have available, but improvements in treatment since then mean that the
survival rates for people now being diagnosed with these cancers may be
higher.
- Survival statistics can sometimes be useful as a
general guide, but they may not accurately represent any one person's
prognosis. A number of other factors, including other tumor
characteristics and a person's age and general health, can also affect
outlook. Your doctor is likely to be a good source as to whether these
numbers may apply to you, as he or she is familiar with the aspects of
your particular situation.
| Stage |
5-year Relative
Survival Rate |
| I |
96% |
| II |
77% |
| III |
73% |
| IV |
37% |
As mentioned above, the stage is not the only factor that
affects survival rates. Other factors, such as the grade of the cancer
(how the cancer cells look under the microscope) and the type of
salivary gland cancer are also important. For more information on the
grades and types of salivary gland cancer, see the section "What
is
salivary gland cancer?"
Last Medical Review: 02/10/2009 Last Revised: 02/10/2009
|